Meet our People
We are groundbreaking leaders, scientists, investors, community luminaries, and thinkers.
Executive Leadership
Marc Appel, JD, MBA
+
Chief Executive Officer & Co-Founder
David Crampton, MBA, MS
+
Chief Financial Officer
Ryan Fox, MS
+
Chief Operating Officer
Lutz Giebel, PhD
+
Executive Chairman of the Board & Co-Founder
Garin Murphy, JD, MBA
+
Chief Business Officer & General Counsel
VENTURES TEAM
Peter Alff, PhD
+
Senior Venture Partner
Rich Ganz, MBA
+
Senior Venture Partner
Michael Kalos, PhD
+
Senior Venture Partner &
Head of Cell Therapy
Laura Crawford PhD, DABT, RAC-Drugs
+
Senior Director,
Drug Development
Brittany Fitzgerald, PhD
+
Chief of Staff to Chief Operating Officer & Associate Director
Nicholas Preiss, PhD
+
Associate Director
Colin Sheehan, PhD
+
Associate Director
Aubrey Smith, PhD
+
Associate Director
Jennifer Vella-Chentorycki, PhD
+
Associate Director
Research & Development Team
William Han, JD, PhD
+
Vice President & Head of
Intellectual Property
Kenneth J. Olivier, PHD
+
Development and Regulatory Advisor
Hua Liao, PhD
+
Vice President & Head of Pharmacology & Biochemistry
William Miller, PhD
+
Vice President & Head of
Medicinal Chemistry
Chris Ryan, PhD
+
Vice President of CMC
Glenn Smits, PhD
+
Vice President of
Non-Clinical Safety and Toxicology
Jason Rizzo, PhD, MD
+
Senior Director &
Head of Translational Biology
Miguel Castellanos, MSc
+
Director of Quality Assurance
Omar Khan, PhD
+
Director of Cell Therapy
Malachi Blundon, PhD
+
Scientific Grant Writer
Diane Yu, PhD
+
Associate Director, Biology
Shruti Parab, MS
+
CMC Consultant
Bruce Weaver, MS
+
CMC Consultant
Legal
Alexander Michalenko, JD, MBA
+
Corporate Counsel
Human Resources
Amanda Hutchins, MS
+
Scientific Recruiter
& Human Resources Generalist
Finance & Accounting
Patricia Howard, MAcc
+
Controller
Brett Katz
+
Investment Analyst
Administrative
Amanda Kneipp
+
Executive Assistant to the Chief Operating Officer & Chief Business Officer
Taylor Negrete
+
Executive Assistant to the Chief Executive Officer